Psilocybin-assisted therapy for stimulant use disorder
Part of Mental health clinical trials.
This study tests whether a psychedelic drug called psilocybin, combined with talk therapy, can help people reduce or stop their use of stimulants like methamphetamine. It aims to see if this treatment is safe and helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 65 years old.
- You have moderate to severe problems with stimulant use, especially methamphetamine.
- You want treatment but are not currently getting other treatment for substance use.
- You have a stable place to live and a friend or family member who can go home with you after the study session.
- You are willing to stop using caffeine, cannabis, stimulants, and other drugs for a few days before the study session.
- You do not have certain health conditions like heart disease, seizures, or a history of psychosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This test uses a safe, non-invasive brain stimulation method called TMS (transcranial magnetic stimulation) to see if it can help people with stimulant use disorder reduce their cravings and stay sober. You would need to be in an addiction treatment program and have been clean for at least 2 weeks to join.
This trial tests whether psilocybin, a psychedelic substance, can help people with moderate to severe methamphetamine use disorder reduce or stop their use. It may work by helping the brain reset, but it's not a standard treatment and involves careful monitoring.
This study tests whether psilocybin (a psychedelic substance) combined with therapy can help people with opioid use disorder. Participants will receive the treatment in a controlled setting and be monitored for safety.
This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.
This trial tests whether psilocybin (a psychedelic medicine) can help people who use methamphetamine and are living with HIV reduce or stop their meth use. You would receive psilocybin in a supervised setting and get counseling support to help you reach your goal of quitting.
This trial tests a non-invasive brain treatment called focused ultrasound for people with stimulant use disorder (like methamphetamine or cocaine). It aims to help reduce cravings and improve recovery by gently stimulating a brain area involved in addiction.
Hear when a new Stimulant Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.